Search results
Blue Medical Devices
Supplier
Author(s):
Daniela Trabattoni
Added:
1 year ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only…
View more
Author(s):
Joseph A Hill
,
Harriette Van Spall
Added:
1 month ago
In this engaging episode of Masterclass filmed at the ACC, host Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with Dr Joseph Hill (UT Southwestern Medical Center, Dallas, TX, US) for a thought-provoking conversation about his career journey, the challenges of medical misinformation, and the critical importance of effective scientific communication.Together, they explore the…
View more
Author(s):
Roxana Mehran
,
Martin Swaans
,
Haim Danenberg
,
et al
Added:
1 year ago
In this video series, first presented at the ESC Congress 2023 held in Amsterdam, Prof Roxana Mehran, Dr Antoinette Neylon, Dr Martin Swaans, Prof Raphael Rosenhek and Prof Haim Danenberg discuss the Expand II TAVR pivotal trial design and the rational for investigating the treatment of moderate aortic stenosis patients with Evolut™ TAVI, provide practical Echo imaging recommendations to improve…
View more
Author(s):
Biykem Bozkurt
,
Muthiah Vaduganathan
,
Start date:
Sep 11, 2024
Join us for an unparalleled educational journey dedicated to tackling the complexities of managing HFpEF and HFmrEF patients. This CME-accredited live roundtable is chaired by Dr Biykem Bozkurt (Baylor College of Medicine, US) and features insights from renowned experts Prof Pardeep Jhund (University of Glasgow, UK) and Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical…
View more
Author(s):
Harold Bays
Added:
1 year ago
ACC.24 — Dr Harold E Bays, Science Officer for the Obesity Medicine Association, a member of the Board of Trustees of the Obesity Medicine Association, and a member of the Board of Directors of the American Society of Preventive Cardiology, joins us to highlight key information regarding weight loss medications in 2024.Support: This is an independent interview conducted by Radcliffe Cardiology…
View more
Author(s):
Joseph A Hill
,
Harriette Van Spall
Added:
1 week ago
In this engaging episode of Masterclass filmed at the ACC, host Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with Dr Joseph Hill (UT Southwestern Medical Center, Dallas, TX, US) for a thought-provoking conversation about his career journey, the challenges of medical misinformation, and the critical importance of effective scientific communication.Together, they explore the…
View more
Author(s):
Michael R Zile
Added:
12 months ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had…
View more
Author(s):
Mandeep Mehra
,
Christian Inchaustegui
Added:
1 year ago
AHA 2023 - Investigator, Dr Mandeep Mehra (Brigham and Women's Hospital, US) is interviewed by Dr Christian Inchaustegui (Oregon Health & Science University, US), CardioNerds Ambassador, on the findings of the ARIES HM3 trial (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES…
View more
Author(s):
Susheel Kodali
Added:
6 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a…
View more